Alps Advisors Inc Xenon Pharmaceuticals Inc. Transaction History

Alps Advisors Inc

$14.8 Billion
Q3 2024

A detailed history of Alps Advisors Inc transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Alps Advisors Inc holds 56,989 shares of XENE stock, worth $2.22 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

56,989

Previous 58,853 3.17%

Holding current value

$2.22 Million

Previous $2.29 Million 2.27%

% of portfolio

0.02%

Previous 0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$36.12 - $43.96 $67,327 - $81,941	-1,864 Reduced 3.17%	56,989 $2.24 Million
Q2 2024 Aug 13, 2024	BUY	$36.25 - $43.75 $204,921 - $247,318	5,653 Added 10.63%	58,853 $2.29 Million
Q1 2024 May 14, 2024	BUY	$42.66 - $50.04 $103,237 - $121,096	2,420 Added 4.77%	53,200 $2.29 Million
Q4 2023 Feb 14, 2024	BUY	$28.7 - $46.46 $98,469 - $159,404	3,431 Added 7.25%	50,780 $2.34 Million
Q3 2023 Nov 14, 2023	BUY	$34.16 - $39.73 $21,384 - $24,870	626 Added 1.34%	47,349 $1.62 Million
Q2 2023 Aug 14, 2023	BUY	$34.84 - $43.54 $180,993 - $226,190	5,195 Added 12.51%	46,723 $1.8 Million
Q1 2023 May 10, 2023	SELL	$33.46 - $40.35 $28,206 - $34,015	-843 Reduced 1.99%	41,528 $1.49 Million
Q4 2022 Feb 14, 2023	BUY	$33.06 - $39.43 $278,100 - $331,685	8,412 Added 24.77%	42,371 $1.67 Million
Q3 2022 Nov 14, 2022	BUY	$30.79 - $39.82 $75,774 - $97,997	2,461 Added 7.81%	33,959 $1.23 Million
Q2 2022 Aug 11, 2022	BUY	$25.44 - $35.16 $801,309 - $1.11 Million	31,498 New	31,498 $958,000
Q1 2022 May 16, 2022	SELL	$25.09 - $33.13 $1.5 Million - $1.98 Million	-59,702 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$15.6 - $35.4 $144,877 - $328,759	9,287 Added 18.42%	59,702 $1.87 Million
Q3 2021 Nov 15, 2021	SELL	$14.86 - $19.45 $52,663 - $68,930	-3,544 Reduced 6.57%	50,415 $770,000
Q2 2021 Aug 11, 2021	SELL	$16.81 - $20.0 $157,543 - $187,440	-9,372 Reduced 14.8%	53,959 $1.01 Million
Q1 2021 May 07, 2021	BUY	$13.65 - $21.31 $1,051 - $1,640	77 Added 0.12%	63,331 $1.13 Million
Q4 2020 Feb 03, 2021	BUY	$9.49 - $16.04 $176,798 - $298,825	18,630 Added 41.75%	63,254 $973,000
Q3 2020 Nov 04, 2020	SELL	$10.82 - $13.35 $33,325 - $41,118	-3,080 Reduced 6.46%	44,624 $494,000
Q2 2020 Aug 05, 2020	BUY	$10.21 - $14.9 $487,057 - $710,789	47,704 New	47,704 $598,000
Q4 2019 Feb 07, 2020	SELL	$8.11 - $14.65 $416,497 - $752,365	-51,356 Closed	0 $0
Q3 2019 Nov 04, 2019	SELL	$8.74 - $10.51 $22,129 - $26,611	-2,532 Reduced 4.7%	51,356 $463,000
Q2 2019 Aug 07, 2019	SELL	$8.51 - $10.75 $60,216 - $76,067	-7,076 Reduced 11.61%	53,888 $531,000
Q1 2019 May 01, 2019	BUY	$6.39 - $10.42 $20,243 - $33,010	3,168 Added 5.48%	60,964 $619,000
Q4 2018 Feb 04, 2019	BUY	$5.61 - $12.62 $324,235 - $729,385	57,796 New	57,796 $365,000

Others Institutions Holding XENE

# of Institutions

212

Shares Held

70.2M

Call Options Held

88.3K

Put Options Held

28.8K

View Full List

About Xenon Pharmaceuticals Inc.

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.42B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

More about XENE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account

Alps Advisors Inc Xenon Pharmaceuticals Inc. Transaction History